). The fusion protein is specifically expressed and translocated into the nucleus upon TM administration, which in turn triggers gene recombination. Since then, this animal model has become a powerful tool to study the molecular mechanism of skeletal development and degenerative cartilage diseases, including knee joint osteoarthritis (OA), temporomandibular joint (TMJ) OA, and intervertebral disc (IVD) degeneration. In this review article, we summarise the application of Col2CreER T2 mice and discuss the potential usage of this animal model in a broad spectrum of cartilage development and molecular pathology studies.
Introduction
Chondrocyte differentiation and maturation are tightly regulated by a series of signalling molecules and transcription factors. Dysregulation of the critical genes leads to degenerative and developmental diseases, such as chondrodysplasia, osteoarthritis (OA), and disc degeneration. A Cre-loxP gene-targeting technique has been widely used to dissect the function of critical genes in cartilage development and pathogenesis. However, conventional and tissue-specific gene deletion approaches can cause embryonic lethality or severe skeletal deformation, given that cartilage functions as a skeletal architect.
Most of the skeleton is formed by endochondral bone formation, a process that involves a cartilage intermediate in which chondrocytes are the sole cell type. In the adult skeleton, cartilage is gradually replaced by bone; the residual hyaline cartilage covering the extremities of bone is termed 'articular cartilage'. Chondrocyte differentiation and maturation are orchestrated by intracellular transcription factors and extracellular signalling molecules. Human genetic studies have identified and characterised a series of genes associated with chondrodysplasia and OA. The study of the functions of these genes largely relies on mouse genetic models in which these genes have been manipulated.
Global gene knockout (KO) technology was achieved by introducing a specific gene mutation by homologous recombination into embryonic stem (ES) cells in vitro, without losing ES cell pluripotency. Upon injection of the ES cells with the gene mutation into blastocysts of foster female mice, the offspring chimeric animals are composed of both mutant and wild-type cells. If the chimeric mice possess the mutant ES cells-derived germ cells, genetic manipulation can be performed. The function of the target gene can be inferred by analysing the mouse phenotype. While global gene KO mice are becoming a powerful tool for identifying gene function, about 15 % of KO mouse strains are embryonically lethal; thus these genetically manipulated animals cannot survive to adulthood. The lethal phenotype observed in KO mice limits studies to embryonic developmental stages and makes it difficult to determine gene function as it relates to human diseases.
The conditional gene KO inactivates the target gene in specific tissues. This technology bypasses the limits of constitutive gene KO and the phenotype observed is more reliably associated with the target gene. The system has two components. The first is the tissue-specifically M Chen et al. Col2CreER transgenic mice expressed Cre enzyme, an integrase from bacteriophage P, and the second is the floxed mouse, in which 34-bp repeats of loxP sites are cloned at both sides of the target gene (Nagy, 2000; Kwan, 2002; Branda and Dymecki, 2004 ) and Cre recombinase has been generated (Feil et al., 1997; Indra et al., 1999; Metzger et al., 2005) . The affinity of the mutant oestrogen receptor to endogenous oestrogen is negligible (Feil et al., 1997) . In the absence of tamoxifen (TM) or 4-hydroxytamoxifen (4-OHT), the fusion protein expresses and localises in the cytoplasm. Upon TM administration to the mice expressing the CreER T2 fusion protein, the ER T2 binds to 4-OHT, a metabolic product of TM, and translocates into the nucleus to induce the deletion of a genomic fragment flanked with loxP sequences (Feil et al., 1997; Indra et al., 1999) . Consequently, the deletion of the target gene can be achieved at specific time points during embryonic development or in postnatal stages by TM treatment.
To overcome the embryonic lethality issue for chondrocyte-specific gene deletion, we generated a chondrocyte-specific and TM-inducible Cre transgenic mouse model (Chen et al., 2007; Zhu et al., 2008) . The transgene DNA is composed of a type II collagen promoter and CreER T2 . Type II collagen is a matrix protein that is detectable in hyaline cartilage, elastic cartilage and fibrocartilage. The type II collagen promoter has been used to generate chondrocyte-specific gene expression in cartilaginous tissues in various mouse models (Schipani et al., 1997; Stricker et al., 2002) . In our Col2CreER T2 mouse model, the expression of CreER T2 , which consists of Cre recombinase fused to a triple mutant form of the human oestrogen receptor ligand binding domain, is driven by the chondrocyte-specific 1.0 kb type II collagen promoter (Tanaka et al., 2000; Tsuda et al., 2003) . The TM-inducible gene deletion system has been examined in vivo in a variety of contexts although there are some concerns about leaking if a strongly expressed promoter is used and the efficiency largely depends on the expression level of the promoter.
Col2CreER

T2 Mice Target: Growth Plate Chondrocytes
Endochondral bone formation is a well-organised process by which long bone is formed. The condensed mesenchymal cells form cartilage as the precursor of bone. Primary and secondary ossification centres are separated by a growth plate, formed by chondrocyte columns with three distinct zones, resting, proliferating and hypertrophic. The growth plate chondrocytes undergo sequential maturation processes. The TM-inducible model has been used to identify the role of critical genes in growth plate chondrocyte differentiation in both developmental and postnatal stages. The efficiency of TM-induced gene recombination was measured by crossing Col2CreER T2 mice with Rosa LacZ reporter mice (Soriano, 1999) . During the embryonic stage, TM was administered to the pregnant female animal (0.1 mg/g body weight of TM in corn oil). The gene recombination was demonstrated by X-gal staining. About 80 % of the chondrocytes of the hind limb were positive for X-gal staining, suggesting high efficiency of TM-induced gene recombination during embryonic development (Chen et al., 2007) . High recombination efficiency of growth plate chondrocytes was also observed in the postnatal Col2CreER T2 ;Rosa mT/mG reporter mice (4 weeks-old) (Fig. 1A,B) , suggesting the usefulness of the application of the animal model in postnatal skeletal development and growth.
The Col2CreER T2 mouse model has been demonstrated to be a powerful tool to achieve gene recombination in both embryonic and postnatal long bone development. Dao et al. investigated the role of β-catenin in embryonic cartilage development in chondrocyte-specific gain-offunction and loss-of-function mouse models by deleting the floxed exon3 or floxed exons 2-6 of the β-catenin gene using TM-inducible Col2CreER T2 mice (Dao et al., 2012) . The deletion of exon3 resulted in the production of a stable β-catenin that was resistant to GSK-3β phosphorylationmediated degradation. TM was injected into pregnant female mice to induce gene recombination at E13.5 when cartilage was just forming during embryonic development. TM induction resulted in the conditional activation and deactivation of β-catenin signalling in chondrocytes with significant developmental defects due to the robust gene recombination. The activation of β-catenin leads to the premature maturation of chondrocytes coupled with enhanced perichondral bone formation. In contrast, inactivation of β-catenin leads to delay of chondrocyte maturation.
Using the same Col2CreER T2 ;β-catenin flox(ex3)/+ mice, reported that, in the postnatal stage, TM-induced chondrocyte-specific β-catenin-activated mice developed local high bone mass, attributed to a β-catenin regulatory mechanism on osteoclastogenesis. Unlike Dao's study (Dao et al., 2012) , TM was injected into postnatal 2-week-old animals and the mice were sacrificed at 3-months-old. At the postnatal stage, activation of β-catenin suppressed the expression of Rankl in chondrocytes and inhibited osteoclastogenesis; whereas mice with the conditional deletion of β-catenin in chondrocytes possessed a bone loss phenotype reversible by treatment with osteoprotegerin (OPG) or by crossing with Col2-Opg transgenic mice . These two studies are examples of using Col2CreER T2 mice to dissect functions of a specific gene at different developmental stages.
Shu et al. reported that a tissue-specific deletion of Bmp2, but not Bmp4, impaired embryonic chondrocyte proliferation and maturation. In their study, TM was injected into 12.5-day pregnant female mice. The deletion of Bmp2, but not Bmp4, altered proliferation and maturation of growth plate chondrocytes in long bones . This inducible model has also been used to study postnatal skeleton growth. Kohn et al. (2012) studied the function of notch signalling in cartilage development and identified that both RBPjkappa-dependent and independent notch signals coordinate chondrocyte differentiation, proliferation and apoptosis.
A cartilage developmental disease, metachondromatosis, is a postnatal skeleton disorder characterised by benign bone tumours of the hands and feet. Genetic studies have revealed an association between the disease and the Shp2 gene. Because homozygous Shp2 -/-mice are embryonic lethal due to multiple defects in gastrulation and mesodermal patterning, the mechanism of SHP2 in skeletal development is largely unknown. Using Col2CreER T2 mice, Kim et al. studied the function of SHP2 in Col2CreER T2 ;Shp2 flox/flox mice. TM was injected into these mice and control mice at 4-weeks of age twice a week for 5 weeks. Loss of Shp2 in the growth plate chondrocytes during the postnatal stage resulted in the development of metachondromatosis (Kim et al., 2014) . This study clearly demonstrated the causal relationship between SHP2 in chondrocytes and metachondromatosis. (Zhu et al., 2009) . Human genetic studies showed that a single nucleotide polymorphism of sFRP3 (R324G) abolished its ability to antagonise Wnt signalling and predisposed patients to OA in weight-bearing joints (Gordon et al., 2007) . Elevated β-catenin was observed in the articular chondrocytes of human OA patients (Zhu et al., 2009; Papathanasiou et al., 2010) . To identify the role of β-catenin in articular cartilage homeostasis, we specifically activated β-catenin in postnatal articular chondrocytes by deletion of β-catenin exon3 using Col2CreER T2 mice (Zhu et al., 2009) . The deletion of exon3 resulted in the production of a stable β-catenin resistant to GSK-3β phosphorylation-mediated degradation. At both 5-and 8-month time points, the activation of β-catenin in chondrocytes resulted in an OAlike phenotype with knee joint articular surface fibrillation, vertical clefting and osteophyte formation. Reductions in Safranin O and Alcian blue staining and articular cartilage thickness were also observed. The expression of the chondrocyte maturation markers, Aggrecan, Mmp9, Mmp13, Alp, OC, and Col10a were consistently and significantly increased. The β-catenin conditional activation study illustrated a causal relationship between elevated β-catenin in articular chondrocytes and OA.
The transforming growth factor-β (TGF-β) signalling pathway is another key signalling pathway associated with the development of OA in human patients (Yang et al., 2001; Yao et al., 2003; Valdes et al., 2010) . A single nucleotide polymorphism in the Smad3 gene is correlated with OA of weight-bearing joints in a cohort of 527 patients (Valdes et al., 2010) . Recent mouse genetic studies indicate that dysregulation of TGF-β signalling induces development of OA via the Smad3 signalling pathway (Li et al., 2006; Li et al., 2010) . To determine the mechanism of inhibition of TGF-β signalling in OA, a conditional KO of TGF-β receptor II was generated by crossing Col2CreER T2 mice with Tgfbr2 flox/flox mice (Shen et al., 2013) . The gene deletion was induced by administering TM to these mice at 2-weeks. Histologic assessments revealed an OA-like phenotype with tears and clefts in articular surfaces and increased numbers of hypertrophic chondrocytes in 3-month-old mice. (Weng et al., 2012) .
In addition to characterising the molecules involved in OA development, Col2CreER T2 is also used to examine potential targets for OA treatment and prevention. Wang et al. (2013a) investigated the role of MMP13 in DMM-induced OA model. After treatment with TM, the Col2CreER T2 ;Mmp13 flox/flox mice had no significant phenotypic change in either the growth plate cartilage or articular cartilage. However, Mmp13 conditional KO mice were resistant to DMM-induced OA, suggesting a therapeutic potential for a MMP13 inhibitor in OA treatment. In the same study, the authors demonstrated that a MMP13 inhibitor efficiently prevented and decelerated progression of OA. The broad application of Col2CreER T2 mice demonstrated the impact of this inducible, tissuespecific model for mechanistic research and prevention of OA.
Col2CreER
T2 Mice Target: Craniofacial Cartilage
The temporomandibular joint (TMJ) is a hinge and gliding joint that connects the condyle of the mandibular bone with a concave, socket-like articular fossa of the temporal bone. It is arguably the most complex synovial joint in humans. Unlike most other synovial joints, the TMJ is bilaterally linked and consists of fibrocartilage. TMJ disorders represent an array of diverse pathological and psychosocial disorders that affect any or all structures within the joint. Among TMJ disorders, OA is the most prevalent degenerative disease arising from pathological conditions, as well as the aging process. TMJ condyle cartilage is divided into three distinct zones, fibrocartilage-like tissue in the superficial zone and hyaline cartilage tissue in the middle and lower zones. During the progression of TMJ OA, the chondrocytes undergo maturation with a phenotype of hypertrophy and apoptosis. The molecular mechanism of TMJ OA parallels knee joint OA, which is marked by the reduction of type II collagen expression and increased expression of hypertrophic markers, such as type X collagen and Runx2. Because the TMJ condyle
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also serves as the mandibular growth centre in postnatal development to provide a larger space for permanent teeth and larger brain capacity, conventional and conditional gene KO targeting the mandibular cartilage may cause severe developmental defects of the mandible. TM-inducible cartilage-specific animal models have also been used to study the role of β-catenin in TMJ arthritis. Gene recombination efficiency was measured by crossing Col2CreER T2 mice with Rosa mT/mG reporter mice. TM was administered to 2-week-old mice and the mice were sacrificed at 1 month to assess recombination efficiency. With TM treatment, over 80 % of TMJ condyle cells were positive for enhanced green fluorescent protein (EGFP), indicating high recombination efficiency (Wang et al., unpublished data) . Two months after TM induction, the Col2CreER T2 ;β-catenin flox(ex3)/+ mice showed a progressive TMJ OA-like phenotype coupled with reduced chondrocyte numbers in the superficial zone, and increased hypertrophic chondrocytes in all three zones. The total cartilage area was decreased significantly, compared to the negative control. The expressions of β-catenin target genes, such as Mmp13 and Adamts5, were consistently elevated. When Mmp13 was deleted in the background of inducible β-catenin conditional activation, the progress of TMJ OA was significantly slower.
Another application of the inducible animal model in craniofacial cartilage development was reported by Wang et al. in Meckel's cartilage development (Wang et al., 2013b (Wang et al., 2013b) . When caBmprIa was activated in chondrocytes, enlarged Meckel's cartilage was observed, suggesting that temporal regulation of BMP signalling is required for normal Meckel's cartilage development.
Col2CreER
T2 Mice Target: Intervertebral Disc
Similar to the TMJ, the intervertebral disc (IVD) is formed by fibrocartilage tissues expressing type II collagen. The IVD consists of an annulus fibrosus (AF) that encloses the nucleus pulposus (NP), a viscous gel-like tissue rich in aggrecan and other proteoglycans. Jin et al. (2011) bred Col2CreER T2 transgenic mice with Rosa LacZ reporter mice to analyse tissue specificity and recombination efficiency of the IVD. TM was injected into animals at 2 weeks of age; the recombination efficiency reached over 75 % at one month and over 70 % at 4 months in both growth plate chondrocytes and the inner AF cells (Fig. 2C) , suggesting slow turnover of IVD chondrocytes . Using this animal model, Jin et al. (2011) (Kim et al., 2013) . TM was injected in 4-week-old mice resulting in 85 % reduction of Shp2 expression. The Shp2-deficient animals exhibited a phenotype of scoliosis and kyphosis.
Tracing the Fate of Col2-Targeting Chondrocytes
CreER T2 transgenic mice have been used for tracing cell fate (Maes et al., 2010) . To determine if TM-induced Cre-mediated recombination is maintained in articular chondrocytes of adult animals, Col2CreER T2 mice were bred with Rosa LacZ reporter mice to follow the course of reporter gene expression. TM was administered to 2-weekold mice and Cre-mediated recombination was examined at 1-and 6-months. The results showed that TM induced efficient Cre recombination in articular chondrocytes in both 1-and 6-months-old mice. The Cre recombination efficiency in articular cartilage of Col2CreER T2 mice was 85 % at 1-month and 82 % at 6-months (Zhu et al., 2008) . These findings suggest that articular chondrocytes have very low turnover rates.
There are two major cell types in the human NP tissue, notochord-like cells and chondrocyte-like cells. The immature disc NP consists of notochordal cells. With NP maturation, notochordal cells are replaced by chondrocytelike cells in the human spine. In mice, small percentages of notochordal cells survive in the postnatal stage. It has been reported that the transition from the notochordal to cartilaginous NP is accomplished by the postnatal migration of chondrocyte-like cells from the cartilage endplate and inner AF region into the notochordal NP region (Kim et al., 2003 (Kim et al., , 2009 Thorsten et al., 2010) . A study using a rabbit model indicated that chondrocytes from the cartilage endplate can migrate toward the NP region as notochordal cells underwent apoptosis (Pazzaglia et al., 1989) . Our in vivo cell tracing studies using Col2CreER T2 ;Rosa LacZ mice demonstrated that no X-gal positive cells migrated from the cartilage endplate and AF cells to the NP region during the postnatal 4-month period ( Fig. 2A,B) . This suggests that, at least in early postnatal mice, chondrocyte-like cells in the NP region are not derived from the surrounding cartilage endplate and AF cells.
Targeting Non-Chondrocyte Cells
To test the targeting specificity of Col2CreER T2 mice, we examined X-gal staining in multiple organs, such as heart, kidney, liver, lung, spleen and skin from Col2CreER T2 ;Rosa LacZ mice. We found that Col2-driving Cre activity was not detectable in these organs (Chen et al., 2007) . These findings suggested that Col2CreER T2 mice have relative specificity for targeting chondrocytes.
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We used another reporter mouse model, Rosa mT/mG mice, to investigate targeting specificity and recombination efficiency. We crossed Col2CreER T2 transgenic mice with Rosa mT/mG mice expressing tomato red and the membranetargeted EGFP (mG) driven by the constitutively active Rosa26 locus. The floxed membrane-targeted tdTomato (mT) cassette with the stop codon located upstream of the EGFP coding sequence is necessary for Cre-mediated excision to allow EGFP expression. Following TM exposure, all GFP-positive cells are those cells expressing Cre recombinase, in which the tomato red sequence was removed from the genome. Those cells in which excision of the stop region does not occur express tomato red only.
Cre recombination efficiency over 80 % was achieved in growth plate chondrocytes of tibiae, determined by calculation of the percentage of GFP-positive cells among all growth plate chondrocytes (Fig. 1A,B ). There were some green signals found within the trabecular bone area (Fig. 1D, upper right) which appear to co-localise with Safranin O-positive staining cells (Fig. 1D , lower right and Fig. 1E, right panel) . These results suggest that the green signals in the trabecular bone area may be unresorbed chondrocytes embedded in bone matrix. However, since the fluorescent picture and SO/FG stained picture are not from the same section, we could not definitely demonstrate that these GFP-positive cells are indeed unreported T2 targeting cells led to activation of hypoxia-inducible factor α (HIFα) signalling and increased bone mass (Weng et al., 2014) ; the phenotype is generally a phenocopy of mice lacking Vhl in mature osteoblasts (Zhao et al., 2012) .
Other Inducible Systems Targeting Chondrocytes
Several investigators have independently generated cartilage-specific, TM-inducible mouse models. In 2006, Nakamura et al. reported the production of Col2CreER T transgenic mice, in which TM injection induced a strong Cre-mediated gene deletion from embryonic day 11 to postnatal day 21 (Nakamura et al., 2006) . Thereafter, the Cre-mediated gene recombination decreased significantly and became undetectable in 12-week-old mice. Although the same type II collagen promoter was used to achieve tissue-specific gene expression, the discrepancy between the mice reported by Nakamura et al. and ours may be due to differences in transgene integration sites and copy numbers. Hilton et al. also generated Col2CreER T transgenic mice, in which TM administration during embryogenesis induced Cre activity in chondrocytes of limbs, but not in the perichondrium (Hilton et al., 2007) .
These authors did not assess the recombination efficiency in postnatal cartilage. In addition to type II collagen, aggrecan is a major extracellular matrix protein in both growth plate and articular cartilage. cDNA into the 3'-UTR of the aggrecan gene to create Agc1CreER T2 mice (Henry et al., 2009) . TM-induced gene recombination in cartilage was documented up to 6-months of age. The authors speculated that Agc1CreER T2 mice could be useful for studying the gene function in adult animals because the aggrecan gene is highly expressed in articular chondrocytes in aged animals when type II collagen expression is diminished.
Summary
We combined tissue-specific and TM-inducible gene targeting technologies and generated a mouse model in which a gene can be inactivated spatiotemporally in chondrocytes. The targeting efficiency of these transgenic mice in different tissues was summarised in Table 1 . This model has been used to identify the role of critical genes in embryonic and postnatal skeletal development Dao et al., 2012; Kohn et al., 2012; Cantley et al., 2013; Wang et al., 2013b) , the progression of arthritis of the knee joint (Zhu et al., 2009; Shen et al., 2013; Wang et al., 2013a) and TMJ (unpublished data) and IVD degeneration Kim et al., 2013b) . In these studies, the targeted genes include β-catenin (Zhu et al., 2009; Dao et al., 2012; Cantley et al., 2013) , BMPs (Shu et al., 2011) , type I and type II BMP receptors (Bmpr1 and Bmpr2) (Wang et al., 2013b) , Mmp13 (Wang et al., 2013a) , www.ecmjournal.org M Chen et al. Col2CreER transgenic mice Shp2 (Kim et al., 2013a; Kim et al., 2013b) , and Tgfbr2 Shen et al., 2013) . While this animal model is widely utilised, one concern is the anabolic effect of TM. TM is a selective oestrogen receptor modulator with oestrogenic and anti-oestrogenic effects. The main clinical use of TM in humans is as an antagonist of oestrogen in breast cancer. In bone, TM is a weak oestrogen agonist and is not used clinically as a selective oestrogen receptor modulator (SERM) (Li et al., 1996) . In rats, daily injections of TM for 28 days (0.1 mg/ kg body weight) resulted in approximately a 20 % increase in bone volume (BV/TV, %) in the tibial metaphysis (Weise et al., 2001) . In our studies, TM was administered on only 5 or fewer occasions and no significant effect on bone was observed .
Oestrogen also has effects on cartilage and regulates growth plate closure and senescence through the oestrogen receptor. Weise et al. performed a comprehensive morphological analysis of the rabbit growth plate and found that oestrogen treatment did not qualitatively alter the growth plate, but did accelerate growth plate senescence (Weise et al., 2001) . Interestingly, in rats with normal hormonal status, 6-weeks of TM administration at 0.02 mg/g body weight had no effect on skeletal growth or bone formation parameters (Weise et al., 2001) . Morphometric features, including width of the growth plate, proliferating region, and hypertrophic zone were unchanged (Weise et al., 2001) .
We can, therefore, conclude that in Col2CreER T2 mice (1) TM (short-term administration) does not cause growth plate senescence or closure; (2) efficient Cre-induced gene recombination can be achieved with only 5 doses of TM, or fewer; (3) data from our studies and those of other groups using Col2CreER T2 mice do not show any obvious changes in growth plate morphology with treatment with TM; and 4) TM-treated controls allow accurate interpretation of observed phenotypes.
